Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-21

Clinical Trial Update: Clinical Investigation of the LAmbre Left Atrial Appendage Closure System [NA]

View source ↗

Summary

The clinical investigation of the LAmbre Left Atrial Appendage Closure System for atrial fibrillation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LAmbre Left Atrial Appendage Closure System (left atrial appendage closure device)

Snippet

Sponsor: Lifetech Scientific (Shenzhen) Co., Ltd. | Conditions: Atrial Fibrillation | NA | Status: COMPLETED